TARGETING GROWTH TO CURE CANCER

OUR INNOVATION

BIMINI Biotech develops innovative therapeutic strategies for oncology

OUR TEAM

BIMINI Biotech combines young entrepreneurs, leading scientists and seasoned biotech business experts

INVESTORS

BIMINI Biotech is currently actively seeking additional funding into the company

NEWS

Keep up-to-date with BIMINI Biotech's latest updates and achievements

Let’s work together to revolutionize oncology therapeutics

BIMINI Biotech is developing therapeutic strategies that target the growth hormone receptor (GHR) and its interaction with insulin-like growth factor 1 (IGF-1) for oncology, metabolic diseases and ageing. We do this through an unique mode-of-action.

BIMINI Biotech is always open for collaborations to accelerate drug development. Please do not hesitate to contact us. 

Key partners

BIMINI Biotech is supported by:

Drukwerk